Stay updated on ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Sign up to get notified when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.

Latest updates to the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page
- Check4 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the Record History, and the 'HHS Vulnerability Disclosure' item as well as the previous 'Revision: v3.3.2' entry were removed from the page footer.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision entry, v3.3.2, was added to the Study Record Versions, replacing the previous v3.3.1. This update pertains to the page's revision history and does not change the study data or visible content.SummaryDifference0.1%

- Check33 days agoChange Detected- The record history now shows a new revision v3.3.1 and removes v3.2.0. - This update affects only version history metadata and does not modify study data or status.SummaryDifference0.1%

- Check40 days agoChange DetectedDeletion removes a general site-wide notice about government funding and operating status from the page. The core content and history records remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check54 days agoChange DetectedNo additions or deletions were detected on the page. The Record History shows no new changes in this view.SummaryDifference0.1%

- Check83 days agoChange DetectedUpdated operating status and funding caveat, with new verification details and a newer revision tag; previous recruitment status and older revision were removed.SummaryDifference16%

Stay in the know with updates to ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.